(Q37819435)
Statements
1 reference
CLEOPATRA: a phase III evaluation of pertuzumab and trastuzumab for HER2-positive metastatic breast cancer (English)
1 reference
José Baselga
1 reference
1 December 2010
1 reference
1 reference
10
1 reference
6
1 reference
489-491
1 reference
Identifiers
1 reference
1 reference